{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:40:02Z","timestamp":1794591602141,"version":"4.9.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005127","name":"FOX","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005127","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ankylosing spondylitis (AS) is chronic inflammatory arthritis with a progressive fusion of axial joints. Anti-inflammatory treatments such as anti-TNF-\u03b1 antibody therapy suppress inflammation but do not effectively halt the progression of spine fusion in AS patients. Here we report that the autoimmune inflammation of AS generates a microenvironment that promotes chondrogenesis in spine ligaments as the process of spine fusion. Chondrocyte differentiation was observed in the ligaments of patients with early-stage AS, and cartilage formation was followed by calcification. Moreover, a large number of giant osteoclasts were found in the inflammatory environment of ligaments and on bony surfaces of calcified cartilage. Resorption activity by these giant osteoclasts generated marrow with high levels of active TGF-\u03b2, which induced new bone formation in the ligaments. Notably, no Osterix<jats:sup>+<\/jats:sup> osteoprogenitors were found in osteoclast resorption areas, indicating uncoupled bone resorption and formation. Even at the late and maturation stages, the uncoupled osteoclast resorption in bony interspinous ligament activates TGF-\u03b2 to induce the progression of ossification in AS patients. Osteoclast resorption of calcified cartilage-initiated ossification in the progression of AS is a similar pathologic process of acquired heterotopic ossification (HO). Our finding of cartilage formation in the ligaments of AS patients revealed that the pathogenesis of spinal fusion is a process of HO and explained why anti-inflammatory treatments do not slow ankylosing once there is new bone formation in spinal soft tissues. Thus, inhibition of HO formation, such as osteoclast activity, cartilage formation, or TGF-\u03b2 activity could be a potential therapy for AS.<\/jats:p>","DOI":"10.1038\/s41413-021-00140-6","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T11:03:23Z","timestamp":1615979003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Chondrogenesis mediates progression of ankylosing spondylitis through heterotopic ossification"],"prefix":"10.1038","volume":"9","author":[{"given":"Tao","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6395-706X","authenticated-orcid":false,"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyu","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qimiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senbo","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9404-540X","authenticated-orcid":false,"given":"Mei","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5032-4893","authenticated-orcid":false,"given":"Shiwu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xisheng","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,17]]},"reference":[{"key":"140_CR1","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","volume":"53","author":"LE Dean","year":"2014","unstructured":"Dean, L. E. et al. Global prevalence of ankylosing spondylitis. Rheumatology (Oxford) 53, 650\u2013657 (2014).","journal-title":"Rheumatology (Oxford)"},{"key":"140_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41413-019-0057-8","volume":"7","author":"W Zhu","year":"2019","unstructured":"Zhu, W. et al. Ankylosing spondylitis: etiology, pathogenesis, and treatments. Bone Res. 7, 22 (2019).","journal-title":"Bone Res"},{"key":"140_CR3","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/S0140-6736(73)91360-3","volume":"1","author":"DA Brewerton","year":"1973","unstructured":"Brewerton, D. A. et al. Ankylosing spondylitis and HL-A 27. Lancet 1, 904\u2013907 (1973).","journal-title":"Lancet"},{"key":"140_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.berh.2018.12.001","volume":"32","author":"RJ Lories","year":"2018","unstructured":"Lories, R. J. Advances in understanding the pathophysiology of spondyloarthritis. Best. Pr. Res Clin. Rheumatol. 32, 331\u2013341 (2018).","journal-title":"Best. Pr. Res Clin. Rheumatol."},{"key":"140_CR5","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1093\/rheumatology\/kei046","volume":"44","author":"J Sieper","year":"2005","unstructured":"Sieper, J. et al. Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 years of treatment with the anti-tumour necrosis factor agent infliximab. Rheumatology (Oxford) 44, 1525\u20131530 (2005).","journal-title":"Rheumatology (Oxford)"},{"key":"140_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.berh.2010.01.005","volume":"24","author":"G Schett","year":"2010","unstructured":"Schett, G. & Rudwaleit, M. Can we stop progression of ankylosing spondylitis? Best. Pr. Res Clin. Rheumatol. 24, 363\u2013371 (2010).","journal-title":"Best. Pr. Res Clin. Rheumatol."},{"key":"140_CR7","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1517\/14712598.2013.839653","volume":"13","author":"D Poddubnyy","year":"2013","unstructured":"Poddubnyy, D. & Rudwaleit, M. Adalimumab for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis\u2014a five-year update. Expert Opin. Biol. Ther. 13, 1599\u20131611 (2013).","journal-title":"Expert Opin. Biol. Ther."},{"key":"140_CR8","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","volume":"10","author":"J Keffer","year":"1991","unstructured":"Keffer, J. et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 10, 4025\u20134031 (1991).","journal-title":"EMBO J."},{"key":"140_CR9","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1136\/ard.2008.102046","volume":"69","author":"S Uderhardt","year":"2010","unstructured":"Uderhardt, S. et al. Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints. Ann. Rheum. Dis. 69, 592\u2013597 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"140_CR10","doi-asserted-by":"publisher","first-page":"R104","DOI":"10.1186\/ar2496","volume":"10","author":"X Baraliakos","year":"2008","unstructured":"Baraliakos, X., Listing, J., Rudwaleit, M., Sieper, J. & Braun, J. The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res Ther. 10, R104 (2008).","journal-title":"Arthritis Res Ther."},{"key":"140_CR11","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1002\/art.23901","volume":"58","author":"D van der Heijde","year":"2008","unstructured":"van der Heijde, D. et al. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum. 58, 3063\u20133070 (2008).","journal-title":"Arthritis Rheum."},{"key":"140_CR12","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/art.23471","volume":"58","author":"D van der Heijde","year":"2008","unstructured":"van der Heijde, D. et al. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum. 58, 1324\u20131331 (2008).","journal-title":"Arthritis Rheum."},{"key":"140_CR13","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1136\/ard.2004.032441","volume":"64","author":"M Rudwaleit","year":"2005","unstructured":"Rudwaleit, M. et al. Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept. Ann. Rheum. Dis. 64, 1305\u20131310 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"140_CR14","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/art.21588","volume":"53","author":"X Baraliakos","year":"2005","unstructured":"Baraliakos, X. et al. Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data. Arthritis Rheum. 53, 856\u2013863 (2005).","journal-title":"Arthritis Rheum."},{"key":"140_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nrrheum.2009.258","volume":"6","author":"WP Maksymowych","year":"2010","unstructured":"Maksymowych, W. P. Disease modification in ankylosing spondylitis. Nat. Rev. Rheumatol. 6, 75\u201381 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"140_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/art.22372","volume":"56","author":"RJU Lories","year":"2007","unstructured":"Lories, R. J. U., Derese, I., de Bari, C. & Luyten, F. P. Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. Arthritis Rheum. 56, 489\u2013497 (2007).","journal-title":"Arthritis Rheum."},{"key":"140_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1136\/annrheumdis-2011-200208","volume":"71","author":"D van der Heijde","year":"2012","unstructured":"van der Heijde, D. et al. MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis. Ann. Rheum. Dis. 71, 369\u2013373 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"140_CR18","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1002\/1529-0131(200009)43:9<2011::AID-ANR12>3.0.CO;2-Y","volume":"43","author":"RJ Fran\u00e7ois","year":"2000","unstructured":"Fran\u00e7ois, R. J., Gardner, D. L., Degrave, E. J. & Bywaters, E. G. Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis. Arthritis Rheum. 43, 2011\u20132024 (2000).","journal-title":"Arthritis Rheum."},{"key":"140_CR19","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s11926-010-0122-1","volume":"12","author":"M Magrey","year":"2010","unstructured":"Magrey, M. & Khan, M. A. Osteoporosis in ankylosing spondylitis. Curr. Rheumatol. Rep. 12, 332\u2013336 (2010).","journal-title":"Curr. Rheumatol. Rep."},{"key":"140_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40674-016-0055-6","volume":"2","author":"AM Hinze","year":"2016","unstructured":"Hinze, A. M. & Louie, G. H. Osteoporosis management in ankylosing spondylitis. Curr. Treatm Opt. Rheumatol. 2, 271\u2013282 (2016).","journal-title":"Curr. Treatm Opt. Rheumatol."},{"key":"140_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/BOR.0b013e3283620777","volume":"25","author":"N Davey-Ranasinghe","year":"2013","unstructured":"Davey-Ranasinghe, N. & Deodhar, A. Osteoporosis and vertebral fractures in ankylosing spondylitis. Curr. Opin. Rheumatol. 25, 509\u2013516 (2013).","journal-title":"Curr. Opin. Rheumatol."},{"key":"140_CR22","first-page":"2740","volume":"127","author":"MA Ulu","year":"2014","unstructured":"Ulu, M. A., Batmaz, \u0130., Dilek, B. & \u00c7evik, R. Prevalence of osteoporosis and vertebral fractures and related factors in patients with ankylosing spondylitis. Chin. Med J. 127, 2740\u20132747 (2014).","journal-title":"Chin. Med J."},{"key":"140_CR23","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/jbmr.3684","volume":"34","author":"KJ Beek","year":"2019","unstructured":"Beek, K. J. et al. Long-term treatment with TNF-alpha inhibitors improves bone mineral density but not vertebral fracture progression in ankylosing spondylitis. J. Bone Min. Res. 34, 1041\u20131048 (2019).","journal-title":"J. Bone Min. Res"},{"key":"140_CR24","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1002\/art.21907","volume":"54","author":"H Appel","year":"2006","unstructured":"Appel, H. et al. Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: evaluation of the bone-cartilage interface and subchondral bone marrow. Arthritis Rheum. 54, 1805\u20131813 (2006).","journal-title":"Arthritis Rheum."},{"key":"140_CR25","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/art.22060","volume":"54","author":"H Appel","year":"2006","unstructured":"Appel, H. et al. Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum. 54, 2845\u20132851 (2006).","journal-title":"Arthritis Rheum."},{"key":"140_CR26","first-page":"13","volume":"19","author":"JF Van Offel","year":"2001","unstructured":"Van Offel, J. F. et al. Influence of cyclic intravenous pamidronate on proinflammatory monocytic cytokine profiles and bone density in rheumatoid arthritis treated with low dose prednisolone and methotrexate. Clin. Exp. Rheumatol. 19, 13\u201320 (2001).","journal-title":"Clin. Exp. Rheumatol."},{"key":"140_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/rheumatology\/ket321","volume":"53","author":"O Viapiana","year":"2014","unstructured":"Viapiana, O. et al. Bisphosphonates vs infliximab in ankylosing spondylitis treatment. Rheumatology (Oxford) 53, 90\u201394 (2014).","journal-title":"Rheumatology (Oxford)"},{"key":"140_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/art.10717","volume":"48","author":"R Singh","year":"2003","unstructured":"Singh, R., Menon, Y., Cuchacovich, R. & Espinoza, L. R. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis: comment on the article by Maksymowych et al. Arthritis Rheum. 48, 583\u2013584 (2003).","journal-title":"Arthritis Rheum."},{"key":"140_CR29","first-page":"144","volume":"28","author":"WP Maksymowych","year":"2001","unstructured":"Maksymowych, W. P. et al. Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. J. Rheumatol. 28, 144\u2013155 (2001).","journal-title":"J. Rheumatol."},{"key":"140_CR30","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/BOR.0b013e328133f57b","volume":"19","author":"E Toussirot","year":"2007","unstructured":"Toussirot, E. & Wendling, D. Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis. Curr. Opin. Rheumatol. 19, 340\u2013345 (2007).","journal-title":"Curr. Opin. Rheumatol."},{"key":"140_CR31","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1093\/rheumatology\/keg256","volume":"42","author":"H Haibel","year":"2003","unstructured":"Haibel, H. et al. Treatment of active ankylosing spondylitis with pamidronate. Rheumatology (Oxford) 42, 1018\u20131020 (2003).","journal-title":"Rheumatology (Oxford)"},{"key":"140_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02988-5","volume":"9","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. Inhibition of overactive TGF-\u03b2 attenuates progression of heterotopic ossification in mice. Nat. Commun. 9, 551 (2018).","journal-title":"Nat. Commun."},{"key":"140_CR33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1056\/NEJM199608223350804","volume":"335","author":"AB Shafritz","year":"1996","unstructured":"Shafritz, A. B. et al. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N. Engl. J. Med. 335, 555\u2013561 (1996).","journal-title":"N. Engl. J. Med."},{"key":"140_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1056\/NEJMoa011262","volume":"346","author":"EM Shore","year":"2002","unstructured":"Shore, E. M. et al. Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia. N. Engl. J. Med. 346, 99\u2013106 (2002).","journal-title":"N. Engl. J. Med"},{"key":"140_CR35","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2106\/00004623-199302000-00009","volume":"75","author":"FS Kaplan","year":"1993","unstructured":"Kaplan, F. S. et al. The histopathology of fibrodysplasia ossificans progressiva. An endochondral process. J. Bone Joint Surg. Am. 75, 220\u2013230 (1993).","journal-title":"J. Bone Joint Surg. Am."},{"key":"140_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14172-4","volume":"11","author":"M Sorkin","year":"2020","unstructured":"Sorkin, M. et al. Regulation of heterotopic ossification by monocytes in a mouse model of aberrant wound healing. Nat. Commun. 11, 722 (2020).","journal-title":"Nat. Commun."},{"key":"140_CR37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1242\/jcs.00229","volume":"116","author":"JP Annes","year":"2003","unstructured":"Annes, J. P., Munger, J. S. & Rifkin, D. B. Making sense of latent TGFbeta activation. J. Cell Sci. 116, 217\u2013224 (2003).","journal-title":"J. Cell Sci."},{"key":"140_CR38","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00296-011-1995-7","volume":"32","author":"A Taylan","year":"2012","unstructured":"Taylan, A. et al. Evaluation of the T helper 17 axis in ankylosing spondylitis. Rheumatol. Int. 32, 2511\u20132515 (2012).","journal-title":"Rheumatol. Int."},{"key":"140_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/ard.2007.084426","volume":"68","author":"S Visvanathan","year":"2009","unstructured":"Visvanathan, S. et al. Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis. Ann. Rheum. Dis. 68, 175\u2013182 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"140_CR40","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nm.1979","volume":"15","author":"Y Tang","year":"2009","unstructured":"Tang, Y. et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat. Med. 15, 757\u2013765 (2009).","journal-title":"Nat. Med"},{"key":"140_CR41","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nm.3143","volume":"19","author":"G Zhen","year":"2013","unstructured":"Zhen, G. et al. Inhibition of TGF-\u03b2 signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat. Med. 19, 704\u2013712 (2013).","journal-title":"Nat. Med"},{"key":"140_CR42","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1002\/jbmr.1691","volume":"27","author":"D Medici","year":"2012","unstructured":"Medici, D. & Olsen, B. R. The role of endothelial-mesenchymal transition in heterotopic ossification. J. Bone Min. Res. 27, 1619\u20131622 (2012).","journal-title":"J. Bone Min. Res."},{"key":"140_CR43","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1172\/JCI70050","volume":"124","author":"JL Crane","year":"2014","unstructured":"Crane, J. L. & Cao, X. Bone marrow mesenchymal stem cells and TGF-\u03b2 signaling in bone remodeling. J. Clin. Invest. 124, 466\u2013472 (2014).","journal-title":"J. Clin. Invest"},{"key":"140_CR44","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.joca.2007.02.005","volume":"15","author":"EN Blaney Davidson","year":"2007","unstructured":"Blaney Davidson, E. N., van der Kraan, P. M. & van den Berg, W. B. TGF-beta and osteoarthritis. Osteoarthr. Cartil. 15, 597\u2013604 (2007).","journal-title":"Osteoarthr. Cartil."},{"key":"140_CR45","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.injury.2011.03.055","volume":"42","author":"K Sarahrudi","year":"2011","unstructured":"Sarahrudi, K. et al. Elevated transforming growth factor-beta 1 (TGF-\u03b21) levels in human fracture healing. Injury 42, 833\u2013837 (2011).","journal-title":"Injury"},{"key":"140_CR46","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1365-2613.2012.00829.x","volume":"93","author":"EJO O\u2019Brien","year":"2012","unstructured":"O\u2019Brien, E. J. O., Frank, C. B., Shrive, N. G., Hallgr\u00edmsson, B. & Hart, D. A. Heterotopic mineralization (ossification or calcification) in tendinopathy or following surgical tendon trauma. Int J. Exp. Pathol. 93, 319\u2013331 (2012).","journal-title":"Int J. Exp. Pathol."},{"key":"140_CR47","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1126\/science.3201241","volume":"242","author":"JM Wozney","year":"1988","unstructured":"Wozney, J. M. et al. Novel regulators of bone formation: molecular clones and activities. Science 242, 1528\u20131534 (1988).","journal-title":"Science"},{"key":"140_CR48","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/nm.3668","volume":"20","author":"H Xie","year":"2014","unstructured":"Xie, H. et al. PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat. Med. 20, 1270\u20131278 (2014).","journal-title":"Nat. Med"},{"key":"140_CR49","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature13145","volume":"507","author":"AP Kusumbe","year":"2014","unstructured":"Kusumbe, A. P., Ramasamy, S. K. & Adams, R. H. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature 507, 323\u2013328 (2014).","journal-title":"Nature"},{"key":"140_CR50","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature13146","volume":"507","author":"SK Ramasamy","year":"2014","unstructured":"Ramasamy, S. K., Kusumbe, A. P., Wang, L. & Adams, R. H. Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature 507, 376\u2013380 (2014).","journal-title":"Nature"},{"key":"140_CR51","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1172\/JCI121561","volume":"129","author":"S Zhu","year":"2019","unstructured":"Zhu, S. et al. Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain. J. Clin. Invest 129, 1076\u20131093 (2019).","journal-title":"J. Clin. Invest"},{"key":"140_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13476-9","volume":"10","author":"S Ni","year":"2019","unstructured":"Ni, S. et al. Sensory innervation in porous endplates by Netrin-1 from osteoclasts mediates PGE2-induced spinal hypersensitivity in mice. Nat. Commun. 10, 5643 (2019).","journal-title":"Nat. Commun."},{"key":"140_CR53","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/nm.2252","volume":"16","author":"D Medici","year":"2010","unstructured":"Medici, D. et al. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat. Med. 16, 1400\u20131406 (2010).","journal-title":"Nat. Med"},{"key":"140_CR54","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.spinee.2013.06.075","volume":"14","author":"AJ Fields","year":"2014","unstructured":"Fields, A. J., Liebenberg, E. C. & Lotz, J. C. Innervation of pathologies in the lumbar vertebral end plate and intervertebral disc. Spine J. 14, 513\u2013521 (2014).","journal-title":"Spine J."},{"key":"140_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","volume":"77","author":"JS Smolen","year":"2018","unstructured":"Smolen, J. S. et al. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann. Rheum. Dis. 77, 3\u201317 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"140_CR56","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1136\/annrheumdis-2015-207897","volume":"75","author":"J Sieper","year":"2016","unstructured":"Sieper, J. et al. Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS). Ann. Rheum. Dis. 75, 1438\u20131443 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"140_CR57","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.semarthrit.2017.04.005","volume":"47","author":"A Deodhar","year":"2017","unstructured":"Deodhar, A. & Yu, D. Switching tumor necrosis factor inhibitors in the treatment of axial spondyloarthritis. Semin Arthritis Rheum. 47, 343\u2013350 (2017).","journal-title":"Semin Arthritis Rheum."},{"key":"140_CR58","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3899\/jrheum.170166","volume":"45","author":"M Hebeisen","year":"2018","unstructured":"Hebeisen, M. et al. Response to tumor necrosis factor inhibition in male and female patients with ankylosing spondylitis: data from a Swiss cohort. J. Rheumatol. 45, 506\u2013512 (2018).","journal-title":"J. Rheumatol."},{"key":"140_CR59","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/sj.sc.3101309","volume":"40","author":"AA van Kuijk","year":"2002","unstructured":"van Kuijk, A. A., Geurts, A. C. & van Kuppevelt, H. J. Neurogenic heterotopic ossification in spinal cord injury. Spinal Cord. 40, 313\u2013326 (2002).","journal-title":"Spinal Cord."}],"container-title":["Bone Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41413-021-00140-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-021-00140-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-021-00140-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:30:33Z","timestamp":1669919433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41413-021-00140-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,17]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["140"],"URL":"https:\/\/doi.org\/10.1038\/s41413-021-00140-6","relation":{},"ISSN":["2095-6231"],"issn-type":[{"value":"2095-6231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,17]]},"assertion":[{"value":"8 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}